IPA fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
ImmunoPrecise Antibodies Ltd. is an AI-driven biotherapeutic research, technology and scientifically robust life science company that discovers and develops customized and novel antibodies by generating proprietary and patented processes, procedures and innovative approaches to antibody discovery, development, and production. The company was founded by Robert Beecroft on November 22, 1983 and is headquartered in Austin, TX.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
IPA has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company